These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30373616)

  • 1. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
    Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
    Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALGENT: A protocol for clinical validation of human papillomavirus assays.
    Arbyn M; Depuydt C; Benoy I; Bogers J; Cuschieri K; Schmitt M; Pawlita M; Geraets D; Heard I; Gheit T; Tommasino M; Poljak M; Bonde J; Quint W
    J Clin Virol; 2016 Mar; 76 Suppl 1():S14-S21. PubMed ID: 26522865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening.
    Arbyn M; Simon M; Peeters E; Xu L; Meijer CJLM; Berkhof J; Cuschieri K; Bonde J; Ostrbenk Vanlencak A; Zhao FH; Rezhake R; Gultekin M; Dillner J; de Sanjosé S; Canfell K; Hillemanns P; Almonte M; Wentzensen N; Poljak M
    Clin Microbiol Infect; 2021 Aug; 27(8):1083-1095. PubMed ID: 33975008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).
    Cuschieri K; Geraets D; Cuzick J; Cadman L; Moore C; Vanden Broeck D; Padalko E; Quint W; Arbyn M
    J Clin Microbiol; 2016 Sep; 54(9):2337-42. PubMed ID: 27385707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.
    Chung PYJ; Dhillon SK; Cortoos S; Hamerlinck H; Pereira R; Padalko E; Vanden Broeck D; Arbyn M
    Microbiol Spectr; 2024 Aug; 12(8):e0033224. PubMed ID: 38916332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
    Dhillon SK; Chung PYJ; Padalko E; Praet M; Pereira AR; Redzic N; Vanden Broeck D; Arbyn M
    J Med Virol; 2023 Sep; 95(9):e29093. PubMed ID: 37702556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
    BMC Cancer; 2020 May; 20(1):396. PubMed ID: 32375689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
    Arbyn M; Snijders PJ; Meijer CJ; Berkhof J; Cuschieri K; Kocjan BJ; Poljak M
    Clin Microbiol Infect; 2015 Sep; 21(9):817-26. PubMed ID: 25936581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.
    Polman NJ; Oštrbenk A; Xu L; Snijders PJF; Meijer CJLM; Poljak M; Heideman DAM; Arbyn M
    J Clin Microbiol; 2017 Dec; 55(12):3544-3551. PubMed ID: 29021152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.
    Frayle H; Gori S; Rizzi M; Graziani BN; Vian E; Giorgi Rossi P; Del Mistro A
    BMC Womens Health; 2019 Mar; 19(1):47. PubMed ID: 30909894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.
    Iacobellis M; Violante C; Notarachille G; Simone A; Scarfì R; Giuffrè G
    Virol J; 2018 Mar; 15(1):48. PubMed ID: 29558950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
    Dhillon SK; Cocuzza CE; Chung PYJ; Martinelli M; Giubbi C; Njoku RC; Bhatia R; Cuschieri K; Arbyn M
    J Med Virol; 2023 Jan; 95(1):e28417. PubMed ID: 36541733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening.
    Gustavsson I; Aarnio R; Myrnäs M; Hedlund-Lindberg J; Taku O; Meiring T; Wikström I; Enroth S; Williamson AL; Olovsson M; Gyllensten U
    Virol J; 2019 Aug; 16(1):107. PubMed ID: 31438976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening.
    Liao Y; Li Q
    Expert Rev Mol Diagn; 2019 Oct; 19(10):857-862. PubMed ID: 31466483
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of EUROArray HPV test using the VALGENT framework.
    Viti J; Poljak M; Oštrbenk A; Bhatia R; Alcañiz Boada E; Cornall AM; Cuschieri K; Garland S; Xu L; Arbyn M
    J Clin Virol; 2018 Nov; 108():38-42. PubMed ID: 30223253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sansure® Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high-risk HPV.
    Prétet JL; Baraquin A; Chung PYJ; Puget L; Dhillon SK; Tkachenka Y; Jacquot K; Lepiller Q; Broeck DV; Arbyn M
    J Med Virol; 2024 Oct; 96(10):e29961. PubMed ID: 39422358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
    Heard I; Cuschieri K; Geraets DT; Quint W; Arbyn M
    J Clin Virol; 2016 Aug; 81():6-11. PubMed ID: 27262102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
    Chung PYJ; Dhillon SK; Baraquin A; Tkachenka Y; Jacquot K; Prétet JL; Broeck DV; Arbyn M
    J Med Virol; 2024 Jun; 96(6):e29688. PubMed ID: 38847316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.